Ranitidine

Shook Taps Partner to Lead New Litigation Strategy Practice Focusing on Co-Counsel Collaboration

Retrieved on: 
Thursday, February 8, 2024
Shook, Hardy & Bacon, MDL, Virtual law firm, Partnership, Ranitidine, Docetaxel, Judicial panel, Product liability, Essure, Lawyer, Ondansetron, CLSC, VLF, Motion

WASHINGTON, Feb. 8, 2024 /PRNewswire/ -- Trial and litigation firm Shook, Hardy & Bacon has named Partner Jennifer Stevenson as co-chair of its newly formed Complex Litigation Strategic Counseling (CLSC) Practice, alongside Partner Patrick Oot. This cross disciplinary group includes the firm's Chambers-ranked Discovery Strategies Practice, which will continue to provide creative and defensible discovery solutions, while offering an array of new strategic counseling services to clients navigating the coordination challenges of mass torts and multidistrict litigation.

Key Points: 
  • WASHINGTON, Feb. 8, 2024 /PRNewswire/ -- Trial and litigation firm Shook, Hardy & Bacon has named Partner Jennifer Stevenson as co-chair of its newly formed Complex Litigation Strategic Counseling (CLSC) Practice, alongside Partner Patrick Oot .
  • "Our Complex Litigation Strategic Counseling Practice offers clients a holistic approach to effectively and efficiently manage multidistrict litigation," said Stevenson.
  • Her litigation successes include pioneering the motion to dismiss and show cause strategy in the In re Zofran (Ondansetron) Products Liability Litigation MDL.
  • "Shook's long history as strategic coordinating counsel in MDLs, mass torts and complex litigation is second to none," said Shook Chair Madeleine McDonough .

Chaffin Luhana Partner, Roopal Luhana Appointed as Co-Lead In Uber Rideshare Litigation

Retrieved on: 
Friday, December 8, 2023
Cream, Woman, Safety, Assault, The Honourable, Advertising, LLP, Plaintiff, FBI, Liability, Trust, Ranitidine, MDL, Rape, District court, Survivor, ESI, Court, News, GSK plc, String interpolation, Ridesharing, Tobacco, Uber, Paraquat

NEW YORK, Dec. 8, 2023 /PRNewswire-PRWeb/ -- The Honorable Charles R. Breyer of the U.S. District Court for the Northern District of California has appointed Chaffin Luhana LLP Founder and Partner, Roopal Luhana as Co-Lead in the Uber Passenger Sexual Assault Litigation MDL (No. 3084).

Key Points: 
  • Roopal Luhana, Founder and Partner at Chaffin Luhana LLP has been appointed as Co-Lead Counsel in the Uber Rideshare Litigation MDL by the U.S. District Court for the Northern District of California.
  • NEW YORK, Dec. 8, 2023 /PRNewswire-PRWeb/ -- The Honorable Charles R. Breyer of the U.S. District Court for the Northern District of California has appointed Chaffin Luhana LLP Founder and Partner, Roopal Luhana as Co-Lead in the Uber Passenger Sexual Assault Litigation MDL (No.
  • Ms. Luhana, who co-founded Chaffin Luhana LLP firm with partner Eric Chaffin in 2010, has many years of experience in consolidated litigation.
  • "I am deeply honored to be appointed as Co-Lead Counsel in the Uber Rideshare Litigation MDL.

Public advisory - Unauthorized health products seized from stores in the Greater Toronto Area because they may pose serious health risks

Retrieved on: 
Wednesday, August 23, 2023
Glaucoma, Retinal detachment, DIN, Elasticity, Hair, Pregnancy, Mouth, Bleeding, Allergy, Prescription drug, Atrophoderma, Xeroderma, Pharmacy, Neostigmine, Blurred vision, Infection, Eye, Weakness, Iris cyst, Health Canada, Cataract, Absorption, Inflammation, Sale, Rash, Plasma protein binding, Itch, Tranexamic acid, Muscle weakness, Nose, NPN, Ranitidine, Dizziness, Nitroglycerin, Aminocaproic acid, Patient, Swelling, Risk, Blood, Drug identification number, Greater Toronto Area, Nausea, Natural product, Health, Headache, Red, Skin, Safety, Hydrochlorothiazide, Common, Dietary supplement

The products are labelled to contain prescription drugs and may pose serious health risks.

Key Points: 
  • The products are labelled to contain prescription drugs and may pose serious health risks.
  • Health Canada is warning consumers about unauthorized Santen brand eye drops that it seized from Asia Food Mart and three L'Amour Beauty locations in the Greater Toronto Area, Ontario.
  • The products are labelled to contain prescription drugs and may pose serious health risks.
  • Unauthorized health products have not been approved by Health Canada, which means that they have not been assessed for safety, efficacy and quality and may pose a range of serious health risks.

Press Release: Sanofi prevails in Zantac arbitration initiated by Boehringer Ingelheim

Retrieved on: 
Tuesday, June 20, 2023
GSK, International, Probability, Rx, Drinking water, European Medicines Agency, Philip Key (U.S. politician), Cancer, BI, Vegetable, NDMA, EMA, Boehringer Ingelheim, MDL, Ranitidine, Soil, OTC, FDA, Safety, International Chamber of Commerce, Commerce, Tobacco, Dietary supplement, Insurance, Pharmaceutical industry, Sanofi, Pfizer

Importantly, Sanofi remains confident that the defense of the underlying U.S. Zantac litigation is very strong.

Key Points: 
  • Importantly, Sanofi remains confident that the defense of the underlying U.S. Zantac litigation is very strong.
  • There is no reliable scientific evidence that Zantac causes the alleged injuries in the cases brought against GSK, Pfizer, BI, Sanofi, and others in the U.S. litigation.
  • In 2006, BI acquired the U.S. OTC rights for Zantac and in January 2017 Sanofi acquired those OTC rights.
  • Given the lack of scientific support for plaintiffs’ claims, Sanofi remains fully confident in its defenses to the litigation.

Judge Appoints Four Attorneys to Lead 77,000 Zantac Cancer Cases in Delaware

Retrieved on: 
Wednesday, May 17, 2023
GSK, GSK plc, Monsanto, Superior court, Cancer, N-Nitrosodimethylamine, NDMA, Liability, Wisner, Ranitidine, Case management, Heartburn, FDA, Roundup, Delaware Superior Court, Pharmaceutical industry, Tobacco

Judge Vivian L. Medinilla named Wisner and three others to the leadership position in a Case Management Order that applies to all Zantac (generic: ranitidine) cancer cases currently pending in the Superior Court of the State of Delaware.

Key Points: 
  • Judge Vivian L. Medinilla named Wisner and three others to the leadership position in a Case Management Order that applies to all Zantac (generic: ranitidine) cancer cases currently pending in the Superior Court of the State of Delaware.
  • "We look forward to presenting evidence at trial that Zantac causes cancer, and that the defendants have known about the risks for decades."
  • More than 77,000 people have Zantac lawsuits pending in Delaware state court alleging the widely used heartburn drug contains a known carcinogen called N-nitrosodimethylamine (NDMA).
  • The trial will be closely followed as the allegations in Mr. Goetz's case share many similarities to cases filed in Delaware.

Baum Hedlund Aristei & Goldman is Now Wisner Baum

Retrieved on: 
Tuesday, January 10, 2023
Plaintiff, Transport, Accident, Retirement, Congress, HPV, MDL, Monsanto, County, Philosophy, DOJ, Culture, FDA, Ranitidine, PC, Hain Celestial Group, LLP, Bayer, The National Law Journal, Lawyer, N-Nitrosodimethylamine, NDMA, The American Lawyer, Goldman, Superior court, Dream, Daily, Tobacco, Pharmaceutical industry, Fine chemical, Gardasil, EU

Los Angeles, California, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Baum Hedlund Aristei & Goldman, PC has changed its name to Wisner Baum, LLP.

Key Points: 
  • Los Angeles, California, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Baum Hedlund Aristei & Goldman, PC has changed its name to Wisner Baum, LLP.
  • Vice president R. Brent Wisner , Baum Hedlund’s lead trial attorney, will serve as Wisner Baum’s new managing partner.
  • “I am honored to have the opportunity to lead this firm into its next chapter and eager to continue the legacy that Michael Baum, Paul Hedlund, Clark Aristei, and Ron Goldman built,” says Wisner.
  • 3:22-cv-00397) appointed Wisner Baum senior partner Bijan Esfandiari to serve as co-lead counsel for plaintiffs.

Chaffin Luhana LLP Welcomes Peter T. Anderson as an Of Counsel Attorney

Retrieved on: 
Tuesday, January 3, 2023
Cream, Counsel, LLP, University, Ranitidine, Personal injury, Peter Anderson (soldier), George Washington University Law School, Commercial software, George Washington University School of Engineering and Applied Science, Science, Survivor, Disease, Paraquat, Parkinson's disease, Insurance, Psychology

NEW YORK, Jan. 3, 2023 /PRNewswire-PRWeb/ -- Chaffin Luhana is proud to announce that Peter T. Anderson has joined the firm effective January 3, 2023, as an Of Counsel Attorney.

Key Points: 
  • Chaffin Luhana LLP continues to grow its mass tort practice by welcoming Peter T. Anderson as an Of Counsel Attorney.
  • NEW YORK, Jan. 3, 2023 /PRNewswire-PRWeb/ -- Chaffin Luhana is proud to announce that Peter T. Anderson has joined the firm effective January 3, 2023, as an Of Counsel Attorney.
  • Mr. Anderson will join the mass tort team at Chaffin Luhana where he will focus primarily on national pharmaceutical and medical device litigation.
  • Chaffin Luhana LLP has provided innovative representation for personal injury victims nationwide in pharmaceutical and medical device cases since 2010.

2022 Outlook on Digestive Remedies in the United States: Size and Shape of the Market - ResearchAndMarkets.com

Retrieved on: 
Monday, December 19, 2022
Health, General Health, Antacid, Ranitidine, Environment, Digestive, Growth, Risk, Food, LBN, Pfizer, GSK, Cancer, Sanofi, Use, Dietary supplement, Pharmaceutical industry, Beauty salon

The "Digestive Remedies in the US" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Digestive Remedies in the US" report has been added to ResearchAndMarkets.com's offering.
  • This is set to drive retail volume and current value decline in H2 blockers in 2022.
  • The Digestive Remedies in USA report offers a comprehensive guide to the size and shape of the market at a national level.
  • Rethinking the relationship with food, and tracking changing consumer demand
    Wonderbelly looks to shake up antacids with a trendily packaged, non-GMO, and plastic-free product
    Table 1 Sales of Digestive Remedies by Category: Value 2017-2022
    Table 2 Sales of Digestive Remedies by Category: % Value Growth 2017-2022
    Table 3 NBO Company Shares of Digestive Remedies: % Value 2018-2022
    Table 4 LBN Brand Shares of Digestive Remedies: % Value 2019-2022
    Table 5 Forecast Sales of Digestive Remedies by Category: Value 2022-2027
    Table 6 Forecast Sales of Digestive Remedies by Category: % Value Growth 2022-2027

Chaffin Luhana and Steelers Running Back Najee Harris Announce New "Student of the Year" Award

Retrieved on: 
Thursday, September 1, 2022
Cream, Partnership, Homelessness, Ranitidine, Najee Harris, Friends, LLP, Poverty, Achievement, Hunger, Student, Parent, Sport, Education, Foundation, School, Instagram, The Science, Engineering & Technology Student of the Year Awards, Partner, Chaffin, Facebook, Face, Gatorade Player of the Year awards, Najee, Family, Medicine, Public relations, Dentistry, Film

PITTSBURGH, Sept. 1, 2022 /PRNewswire-PRWeb/ -- Chaffin Luhana LLP and the Chaffin Luhana Foundation, in partnership with Pittsburgh Steelers Running Back Najee Harris, are excited to announce a new scholarship award for one deserving high school student in the greater Pittsburgh community.

Key Points: 
  • Chaffin Luhana and Najee Harris partner to award one deserving student that exemplifies the Doing Good by Doing Right values within their community.
  • PITTSBURGH, Sept. 1, 2022 /PRNewswire-PRWeb/ -- Chaffin Luhana LLP and the Chaffin Luhana Foundation, in partnership with Pittsburgh Steelers Running Back Najee Harris, are excited to announce a new scholarship award for one deserving high school student in the greater Pittsburgh community.
  • "This season, I'm teaming up with Chaffin Luhana to award a deserving student with a scholarship and a pep rally with me at their school.
  • "We're excited to be working with Najee to offer this award and scholarship to a deserving student," said Roopal Luhana, Partner of Chaffin Luhana.

PERRIGO RELEASES STATEMENT ON RECENT MARKET TRADING ACTIVITY

Retrieved on: 
Wednesday, August 17, 2022
FDA, U.S. Securities and Exchange Commission, Prejudice, Multimedia, Risk, Industry, NYSE, Cancer, Terminology, Rx, Sale, Consumer, Government, Marketing, Assessment, Madison County, COVID-19, Boehringer Ingelheim, Company, Ranitidine, Acquisition, OTC, PRGO, Coronavirus, Intention, News, Health, Machine shop, Perrigo, Bayer

The August 16, 2022 notice of dismissal of claims, and impending trial, against the branded companies did not involve Perrigo.

Key Points: 
  • The August 16, 2022 notice of dismissal of claims, and impending trial, against the branded companies did not involve Perrigo.
  • Further, as a private label manufacturer, Perrigo has additional defenses under federal preemption.
  • These defenses have been successfully used to obtain dismissals in the majority of ranitidine cases involving Perrigo.
  • To date, Perrigo has successfully won multiple Motions to Dismiss in the federal multi-district litigation and state court actions in California and Maryland.